---
title: "石藥集團獲得監管機構的批准以啓動藥物試驗"
description: "石藥集團獲得監管批准開始藥物試驗"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276035104.md"
published_at: "2026-02-16T06:01:00.000Z"
---

# 石藥集團獲得監管機構的批准以啓動藥物試驗

> 石藥集團獲得監管批准開始藥物試驗

### Related Stocks

- [01093.HK - 石藥集團](https://longbridge.com/zh-HK/quote/01093.HK.md)
- [512290.CN - 國泰中證生物醫藥ETF](https://longbridge.com/zh-HK/quote/512290.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-HK/news/276056763.md) |
| CSPC Pharma Gets China Nod for Multiple Drug Trials | CSPC Pharma Gets China Nod for Multiple Drug Trials | [Link](https://longbridge.com/zh-HK/news/270994613.md) |
| MHRA says licensed brensocatib as first drug for non-cystic fibrosis bronchiectasis in patients aged 12+ | MHRA says licensed brensocatib as first drug for non-cystic fibrosis bronchiectasis in patients aged 12+ | [Link](https://longbridge.com/zh-HK/news/276584133.md) |
| VA reverses on new disability rating rule after intense backlash | The Department of Veterans Affairs (VA) has reversed a controversial rule that calculated veterans' disability ratings b | [Link](https://longbridge.com/zh-HK/news/276476721.md) |
| Sunshine Lake Pharma Wins NMPA Nod to Trial First China-Developed Nipah Virus Antibody | Sunshine Lake Pharma has received approval from China's Center for Drug Evaluation to begin clinical trials for HEC-648  | [Link](https://longbridge.com/zh-HK/news/276716153.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。